Skip to main content

Table 3 Comparison of data before and 4 h after treatment among study groups

From: Evaluation of inhaled beta-2 agonist in management of transient tachypnea of the newborn

Variable

Group I (saline)

P value

Group II (salbutamol)

P value

Before

After

Before

After

Respiratory rate (breath/min)

74.36 ± 8.08

71.47 ± 8.15

0.09

72.11 ± 7.56

62.59 ± 7.43

0.0001

Heart rate (beats/min)

148.32 ± 11.52

146.33 ± 22.28

0.17

144.78 ± 10.34

142.72 ± 10.25

0.13

TTN score*

7 (6–9)

7 (5–9)

0.06

8 (7–10)

3 (3–5)

0.0000

PH

7.28 ± 0.14

7.31 ± 0.09

0.26

7.26 ± 0.13

7.36 ± 0.07

0.0001

FiO2 (%)*

65(50–75)

60(45–75)

0.06

65(50–80)

30(25–45)

0.0000

PaO2 (mmHg)

68.04 ± 10.03

71.58 ± 9.98

0.09

67.69 ± 11.19

81.77 ± 10.84

0.0000

PaCO2 (mmHg)

44.21 ± 6.74

46.17 ± 6.42

0.16

45.48 ± 6.53

40.33 ± 6.76

0.03

Serum K (mEq/L)

4.24 ± 0.68

4.37 ± 0.71

0.38

4.36 ± 0.64

4.15 ± 0.61

0.07

Glucose (mg/dl)

79.04 ± 10.17

77.85 ± 9.73

0.29

77.81 ± 10.19

80.26 ± 9.94

0.23

  1. *Median